KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cognex (CGNX) Research & Development (2016 - 2025)

Historic Research & Development for Cognex (CGNX) over the last 17 years, with Q3 2025 value amounting to $35.1 million.

  • Cognex's Research & Development fell 36.64% to $35.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.4 million, marking a year-over-year decrease of 459.39%. This contributed to the annual value of $139.8 million for FY2024, which is 29.77% up from last year.
  • Cognex's Research & Development amounted to $35.1 million in Q3 2025, which was down 36.64% from $33.1 million recorded in Q2 2025.
  • In the past 5 years, Cognex's Research & Development ranged from a high of $38.5 million in Q2 2023 and a low of $31.3 million during Q3 2021
  • Moreover, its 5-year median value for Research & Development was $34.7 million (2023), whereas its average is $34.7 million.
  • In the last 5 years, Cognex's Research & Development soared by 1400.79% in 2021 and then crashed by 657.35% in 2023.
  • Quarter analysis of 5 years shows Cognex's Research & Development stood at $35.5 million in 2021, then rose by 4.64% to $37.1 million in 2022, then decreased by 6.57% to $34.7 million in 2023, then decreased by 6.21% to $32.5 million in 2024, then increased by 7.82% to $35.1 million in 2025.
  • Its Research & Development stands at $35.1 million for Q3 2025, versus $33.1 million for Q2 2025 and $34.7 million for Q1 2025.